anti-Influenza A antibody product blogThe Influenza A n/a (Catalog #MBS531531) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Influenza An antibody reacts with Influenza An and may cross-react with other species as described in the data sheet. MyBioSource\'s Influenza A can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF).
Matched pair antibodies available for Influenza An antibody: MBS531149, MBS530833. Researchers should empirically determine the suitability of the Influenza A n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal Influenza An antibody.
Biological Significance: Influenza A virus causes influenza in birds and some mammals and is the only species of Influenzavirus A. Influenzavirus An is a genus of the Orthomyxoviridae family of viruses. Strains of all subtypes of influenza A virus have been isolated from wild birds, although disease is uncommon. Some isolates of influenza A virus cause severe disease both in domestic poultry and, rarely, in humans. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: Influenza An antibody was raised in Mouse using Influenza A nucleoprotein as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Influenza An are readily searchable from our website. Different antibodies against the same target such as Influenza A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.